FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Semaglutide (WEGOVY®) Injection
Status: Currently in Shortage
»Date first posted: 03/31/2022
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Novo Nordisk, Inc. (Revised 05/04/2023)

Company Contact Information:
833-493-4689

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.25 mg / 0.5mL (NDC 0169-4525-14)	Limited availability through September 2023		Demand increase for the drug
0.5 mg / 0.5mL (NDC 0169-4505-14)	Limited availability through September 2023		Demand increase for the drug
1 mg / 0.5mL (NDC 0169-4501-14)	Limited availability through September 2023		Demand increase for the drug
1.7 mg / 0.75mL (NDC 0169-4517-14)	Available
2.4 mg / 0.75mL (NDC 0169-4524-14)	Available